Inovio 製藥公司

簡介

本頁面提供了有關 Simon X Benito 已知的內部交易歷史的全面分析。內部人士包括公司的高管、董事或重要投資者。一般而言,基於內幕、非公開信息進行交易是非法的。這並不意味著他們在自己的公司進行任何交易都是非法的。但是,他們必須透過Form 4向美國證券交易委員會(SEC)報告所有交易。盡管存在這些限制,學術研究表明,內部人士 - 整體而言 - 在自己公司中的投資表現往往優於市場。

平均交易盈利能力

「平均交易盈利能力」衡量了內部人士在過去三年中所有非計劃性的公開市場購買交易的平均回報率。計算過程包括檢查每筆交易,排除了作為10b5-1交易計劃的一部分的交易。然後,對每筆交易在3、6和12個月的表現進行平均,以生成該筆交易最終的表現指標。最終,將所有交易的表現指標進行平均,計算出內部人士的總體平均表現指標。列表僅包含在過去兩年中進行過至少三筆交易的內部人士。

如果內部人士的交易盈利能力顯示為"N/A",則可能是因為該內部人士在過去三年內沒有進行任何公開市場購買交易,或者他們進行的交易距離現在太近,無法計算出可靠的表現指標。

更新頻率:每日

查看收益最高的的內幕交易者列表。

報告內部持倉的公司

SEC文件顯示Simon X Benito已報告在以下公司擁有持倉或進行了交易:

證券 職位 最新報告的持倉
US:INO / Inovio Pharmaceuticals, Inc. Director 12,191
US:DRRX / DURECT Corporation Director 105,000
如何解讀這些圖表

以下圖表顯示了在Simon X Benito進行的每筆公開市場非計劃交易後證券的股價表現。非計劃交易是指沒有作為10b5-1交易計劃的一部分而進行的交易。股價表現以累積百分比變化的方式繪製。例如,如果一筆內部人士交易是在2019年1月1日進行的,該圖表將顯示該證券的每日百分比變化直至當前日期。如果在此期間股價從10美元漲至15美元,則股價的累積百分比變化將為50%。從10美元漲至20美元的價格變化將為100%,而從10美元跌至5美元的價格變化將為-50%。

最終,我們將評估內部人士的交易與股價的超額回報(正向或負向)之間的相關性,以判斷內部人士是否在交易中利用內部信息獲利。如果內部人士有這樣的行為,我們預期看到(a)購買後的正回報,或者(b)賣出後的負回報。對於情況(a),購買圖表將顯示一系列向上傾斜的曲線,表示每次購買後都有正回報。對於情況(b),賣出圖表將顯示一系列向下傾斜的曲線,表示每次賣出後都有負回報。

然而,僅憑這一點還不足以得出結論。例如,如果公司的股價在多年內呈現非周期性上升,我們會預期所有購買後的圖表都呈現向上傾斜。同樣地,多年來呈現非周期性下降的股價會導致賣出後的圖表也呈現向下傾斜。這兩種情況的圖表都不能表示內部人士在進行內幕交易。

最有力的指標是在公司股價呈極度循環波動的情況下,「購買」圖表顯示正向信號,而「賣出」圖表顯示負向趨勢。這種情況強烈暗示內部人士可能根據內幕信息精確地計時進行交易,以獲得財務優勢。

INO / Inovio Pharmaceuticals, Inc.內部人士買入 - 短期收益分析

在這一部分,我們分析了在 INO / Inovio Pharmaceuticals, Inc. 中進行的每筆非計劃的公開市場內部人士購買的盈利情況。這種分析有助於了解內部人士是否持續產生異常的回報,以及是否值得跟踪。該分析基於每筆交易後一年的情況,結果僅為理論值

以下表格顯示了最近的自動交易計劃之外的公開市場購買。

交易日期 證券代碼 內部人士 報告
股數
Reported
價格
經調整
股數
經調整
價格
成本基礎 達到最高利潤的
天數
達到最高利潤時的
價格
最高
淨利 ($)
最高回報率(%)
2015-08-14 INO BENITO SIMON X 6,000 7.2096 500 86.5152 43,258 293 136.68 25,083 57.99

經調整價格 已按拆股調整。經調整股數 已按拆股調整。

INO / Inovio Pharmaceuticals, Inc. Insider Trades
INO / Inovio Pharmaceuticals, Inc.內部人士賣出 - 短期虧損分析

在這一部分,我們分析了在 INO / Inovio Pharmaceuticals, Inc. 中進行的每筆非計劃的公開市場內部人士賣出所達成的短期虧損規避。如果存在持續的虧損規避模式,可能表明未來的內部人士賣出交易預示著價格的下跌。該分析基於每筆交易後一年的情況,

以下表格顯示了最近的自動交易計劃之外的公開市場購買。

交易日期 證券代碼 內部人士 報告
股數
Reported
價格
經調整
股數
經調整
價格
成本基礎 達到最低利潤的
天數
達到最低利潤時的
價格
避免的
最高損失金額($)
避免的
最高損失率($)
2020-05-20 INO BENITO SIMON X 8,750 15.9536 729 191.4432 139,594 358 74.76 -85,094 -60.96
2018-04-12 INO BENITO SIMON X 3,750 5.2317 312 62.7804 19,619
2016-05-18 INO BENITO SIMON X 6,250 10.3710 521 124.4520 64,819

經調整價格 已按拆股調整。經調整股數 已按拆股調整。

INO / Inovio Pharmaceuticals, Inc. Insider Trades
歷史內部人交易

該表格顯示了由 Simon X Benito 進行的所有內幕交易的完整列表,這些交易已向美國證券交易委員會(SEC)披露。

呈報日期 交易日期 表格 證券代碼 證券 代碼 10b5-1 股份 剩餘股份 %
變化
每股
股價
交易
金額
剩餘
金額
2025-05-21 2025-05-21 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
M - Exercise 2,167 12,191 21.62
2024-05-16 2024-05-15 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
M - Exercise 2,166 10,024 27.56
2023-05-16 2023-05-16 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
M - Exercise 19,000 94,305 25.23
2022-07-20 2022-07-20 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
S - Sale X -2,000 75,305 -2.59 2.25 -4,500 169,436
2022-07-20 2022-07-20 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
M - Exercise 2,000 77,305 2.66 2.20 4,400 170,071
2022-05-17 2022-05-16 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock Options
A - Award 28,000 28,000
2022-05-17 2022-05-16 4 INO INOVIO PHARMACEUTICALS, INC.
Restricted Stock Unit
A - Award 19,000 19,000
2022-05-17 2022-05-13 4 INO INOVIO PHARMACEUTICALS, INC.
Restricted Stock Unit
M - Exercise -18,000 0 -100.00
2022-05-17 2022-05-13 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
M - Exercise 18,000 75,305 31.41
2022-03-17 2022-03-16 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock Options
M - Exercise -2,000 6,000 -25.00
2022-03-17 2022-03-16 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
S - Sale X -2,000 57,305 -3.37 3.16 -6,320 181,084
2022-03-17 2022-03-16 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
M - Exercise 2,000 59,305 3.49 2.20 4,400 130,471
2022-01-21 2022-01-19 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock Options
M - Exercise -2,000 8,000 -20.00
2022-01-21 2022-01-19 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
S - Sale X -2,000 57,305 -3.37 4.27 -8,540 244,692
2022-01-21 2022-01-19 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
M - Exercise 2,000 59,305 3.49 2.20 4,400 130,471
2021-12-09 2021-12-07 4 DRRX DURECT CORP
Common Stock
P - Purchase 20,000 105,000 23.53 1.02 20,360 106,890
2021-06-16 2021-06-15 4 DRRX DURECT CORP
Stock Option (right to buy)
A - Award 55,000 55,000
2021-05-17 2021-05-17 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
S - Sale X -3,045 57,305 -5.05 6.62 -20,158 379,359
2021-05-17 2021-05-14 4 INO INOVIO PHARMACEUTICALS, INC.
Restricted Stock Unit
M - Exercise -8,700 0 -100.00
2021-05-17 2021-05-14 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
M - Exercise 8,700 60,350 16.84
2021-05-17 2021-05-13 4 INO INOVIO PHARMACEUTICALS, INC.
Restricted Stock Unit
A - Award 18,000 18,000
2021-05-17 2021-05-13 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock Options
A - Award 27,000 27,000
2021-04-16 2021-04-16 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock Options
M - Exercise -2,000 0 -100.00
2021-04-16 2021-04-16 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
S - Sale X -2,000 51,650 -3.73 8.75 -17,500 451,938
2021-04-16 2021-04-16 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
M - Exercise 2,000 53,650 3.87 3.56 7,120 190,994
2021-03-16 2021-03-16 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock Options
M - Exercise -2,000 2,000 -50.00
2021-03-16 2021-03-16 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
S - Sale X -2,000 51,650 -3.73 10.41 -20,820 537,676
2021-03-16 2021-03-16 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
M - Exercise 2,000 53,650 3.87 3.56 7,120 190,994
2021-02-18 2021-02-16 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock Options
M - Exercise -2,000 4,000 -33.33
2021-02-18 2021-02-16 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
S - Sale X -2,000 51,650 -3.73 14.68 -29,360 758,222
2021-02-18 2021-02-16 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
M - Exercise 2,000 53,650 3.87 3.56 7,120 190,994
2021-01-05 2021-01-04 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock Options
M - Exercise -2,750 6,000 -31.43
2021-01-05 2021-01-04 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
S - Sale X -2,750 51,650 -5.06 9.00 -24,750 464,850
2021-01-05 2021-01-04 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
M - Exercise 2,750 54,400 5.32 3.56 9,790 193,664
2020-06-18 2020-06-17 4 DRRX DURECT CORP
Non-Qualified Stock Option (right to buy)
A - Award 55,000 55,000
2020-05-20 2020-05-20 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock Option
M - Exercise -8,750 0 -100.00
2020-05-20 2020-05-20 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
S - Sale -8,750 51,650 -14.49 15.95 -139,594 824,003
2020-05-20 2020-05-20 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
M - Exercise 8,750 60,400 16.94 4.60 40,250 277,840
2020-05-15 2020-05-14 4 INO INOVIO PHARMACEUTICALS, INC.
Restricted Stock Unit
A - Award 8,700 8,700
2020-05-15 2020-05-14 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock Options
A - Award 13,300 13,300
2020-05-08 2020-05-08 4 INO INOVIO PHARMACEUTICALS, INC.
Restricted Stock Unit
M - Exercise -8,013 0 -100.00
2020-05-08 2020-05-08 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
M - Exercise 8,013 51,650 18.36
2019-06-20 2019-06-19 4 DRRX DURECT CORP
Non-Qualified Stock Option (right to buy)
A - Award 55,000 55,000
2019-05-13 2019-05-11 4 INO INOVIO PHARMACEUTICALS, INC.
Restricted Stock Unit
M - Exercise -8,170 0 -100.00
2019-05-13 2019-05-11 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
M - Exercise 8,170 43,637 23.04
2019-05-09 2019-05-08 4 INO INOVIO PHARMACEUTICALS, INC.
Restricted Stock Unit
A - Award 8,013 8,013
2019-05-09 2019-05-08 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock Options
A - Award 12,500 12,500
2018-06-20 2018-06-19 4 DRRX DURECT CORP
Non-Qualified Stock Option (right to buy)
A - Award 55,000 55,000
2018-05-14 2018-05-12 4 INO INOVIO PHARMACEUTICALS, INC.
Restricted Stock Unit
M - Exercise -7,669 0 -100.00
2018-05-14 2018-05-12 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
M - Exercise 7,669 35,467 27.59
2018-05-14 2018-05-11 4 INO INOVIO PHARMACEUTICALS, INC.
Restricted Stock Unit
A - Award 8,170 8,170
2018-05-14 2018-05-11 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock Options
A - Award 12,500 12,500
2018-04-13 2018-04-12 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock Options
M - Exercise -3,750 0 -100.00
2018-04-13 2018-04-12 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
S - Sale -3,750 27,798 -11.89 5.23 -19,619 145,431
2018-04-13 2018-04-12 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
M - Exercise 3,750 31,548 13.49 3.56 13,350 112,311
2017-09-26 2017-09-25 4 DRRX DURECT CORP
Non-Qualified Stock Option (right to buy)
M - Exercise -25,000 0 -100.00
2017-09-26 2017-09-25 4 DRRX DURECT CORP
Common Stock
M - Exercise 25,000 85,000 41.67 0.82 20,495 69,683
2017-06-21 2017-06-19 4 DRRX DURECT CORP
Non-Qualified Stock Option (right to buy)
A - Award 16,038 71,038 29.16 1.06 17,000 75,300
2017-06-21 2017-06-19 4 DRRX DURECT CORP
Non-Qualified Stock Option (right to buy)
A - Award 55,000 55,000
2017-05-15 2017-05-13 4 INO INOVIO PHARMACEUTICALS, INC.
Restricted Stock Unit
M - Exercise -10,000 0 -100.00
2017-05-15 2017-05-13 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
M - Exercise 10,000 27,798 56.19
2017-05-15 2017-05-12 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock Options
A - Award 12,500 12,500
2017-05-15 2017-05-12 4 INO INOVIO PHARMACEUTICALS, INC.
Restricted Stock Unit
A - Award 7,669 7,669
2016-06-23 2016-06-22 4 DRRX DURECT CORP
Non-Qualified Stock Option (right to buy)
A - Award 35,000 35,000
2016-05-18 2016-05-18 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock Options
M - Exercise -6,250 0 -100.00 8.92 -55,750
2016-05-18 2016-05-18 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
S - Sale -6,250 17,798 -25.99 10.37 -64,819 184,583
2016-05-18 2016-05-18 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
M - Exercise 6,250 24,048 35.12 8.92 55,750 214,508
2016-05-16 2016-05-13 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock Options
A - Award 10,000 10,000 9.33 93,300 93,300
2016-05-16 2016-05-13 4 INO INOVIO PHARMACEUTICALS, INC.
Restricted Stock Unit
A - Award 10,000 10,000
2016-05-09 2016-05-08 4 INO INOVIO PHARMACEUTICALS, INC.
Restricted Stock Unit
M - Exercise -5,000 0 -100.00
2016-05-09 2016-05-08 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
M - Exercise 5,000 17,798 39.07
2016-04-04 2016-03-31 4 DRRX DURECT CORP
Non-Qualified Stock Option (right to buy)
A - Award 14,423 14,423 1.04 15,000 15,000
2015-08-17 2015-08-14 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock
P - Purchase 6,000 12,798 88.26 7.21 43,258 92,268
2015-06-16 2015-06-15 4 DRRX DURECT CORP
Non-Qualified Stock Option (right to buy)
A - Award 35,000 35,000
2015-05-08 2015-05-08 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock Option
A - Award 7,500 7,500 8.01 60,075 60,075
2015-05-08 2015-05-08 4 INO INOVIO PHARMACEUTICALS, INC.
Restricted Stock Unit
A - Award 5,000 5,000
2015-03-30 2015-03-26 4 DRRX DURECT CORP
Non-Qualified Stock Option (right to buy)
A - Award 11,111 11,111
2015-03-10 2015-03-10 4 DRRX DURECT CORP
Common Stock
P - Purchase 40,000 60,000 200.00 1.81 72,260 108,390
2014-06-17 2014-06-16 4 DRRX DURECT CORP
Non-Qualified Stock Option (right to buy)
A - Award 35,000 35,000
2014-05-23 2014-05-22 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock Option
A - Award 40,000 40,000 2.20 88,000 88,000
2014-04-01 2014-03-28 4 DRRX DURECT CORP
Non-Qualified Stock Option (right to buy)
A - Award 14,423 14,423
2013-06-26 2013-06-25 4 DRRX DURECT CORP
Non-Qualified Stock Option (right to buy)
A - Award 35,000 35,000
2013-05-20 2013-05-17 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock Option
A - Award 40,000 40,000 0.67 26,800 26,800
2013-02-07 2013-02-05 4 DRRX DURECT CORP
Non-Qualified Stock Option (right to buy)
A - Award 18,987 18,987
2012-08-13 2012-08-10 4 INO INOVIO PHARMACEUTICALS, INC.
Common Stock Options
A - Award 40,000 40,000 0.55 22,000 22,000
2012-06-21 2012-06-20 4 DRRX DURECT CORP
Non-Qualified Stock Option (right to buy)
A - Award 25,000 25,000
P
非衍生或衍生證券的公開市場或私下買入
S
非衍生或衍生證券的公開市場或私下賣出
A
公司向內部人員授予、獎勵或以其他方式獲取證券(例如股票期權)
C
衍生工具轉換
D
將證券賣出或轉讓回公司
F
使用從公司收到的證券的一部分來支付行使價或稅務負擔。
G
內部人士贈送或接收他人贈送公司股票
K
股權掉期和類似的避險交易
M
行使或轉換從公司獲得的衍生證券(例如期權)
V
內部人士透過Form 4自願報告的一筆交易
J
其他(附有交易描述的腳註)